AAAAAA

   
Results: 1-25 | 26-50 | 51-61
Results: 26-50/61
CETP ACTIVITY DURING POSTPRANDIAL LIPEMIA - EVIDENCE FOR A LOW CHYLOMICRON CE ACCEPTOR ACTIVITY
Authors: LASSEL TS GUERIN M AUBOIRON S GUYGRAND B CHAPMAN MJ
Citation: Ts. Lassel et al., CETP ACTIVITY DURING POSTPRANDIAL LIPEMIA - EVIDENCE FOR A LOW CHYLOMICRON CE ACCEPTOR ACTIVITY, Atherosclerosis, 134(1-2), 1997, pp. 369-369
EFFECT OF THE OXIDATION-STATE OF LDL ON THE MODULATION OF ARTERIAL VASOMOTOR RESPONSE IN-VITRO
Authors: MOUGENOT N LESNIK P RAMIREZGIL JF NATAF P DICZFALUSY U CHAPMAN MJ LECHAT P
Citation: N. Mougenot et al., EFFECT OF THE OXIDATION-STATE OF LDL ON THE MODULATION OF ARTERIAL VASOMOTOR RESPONSE IN-VITRO, Atherosclerosis, 133(2), 1997, pp. 183-192
FAMILIAL LECITHIN - CHOLESTEROL ACYLTRANSFERASE DEFICIENCY - MOLECULAR ANALYSIS OF A COMPOUND HETEROZYGOTE - LCAT (ARG(147)-]TRP) AND LCAT (TYR(171)-]STOP)
Authors: GUERIN M DACHET C GOULINET S CHEVET D DOLPHIN PJ CHAPMAN MJ ROUIS M
Citation: M. Guerin et al., FAMILIAL LECITHIN - CHOLESTEROL ACYLTRANSFERASE DEFICIENCY - MOLECULAR ANALYSIS OF A COMPOUND HETEROZYGOTE - LCAT (ARG(147)-]TRP) AND LCAT (TYR(171)-]STOP), Atherosclerosis, 131(1), 1997, pp. 85-95
FAMILIAL LECITHIN - CHOLESTEROL ACYLTRANSFERASE DEFICIENCY - MOLECULAR ANALYSIS OF A COMPOUND HETEROZYGOTE - LCAT (ARG(147)-]TRP) AND LCAT (TYR(171)-]STOP)
Authors: GUERIN M DACHET C GOULINET S CHEVET D DOLPHIN PJ CHAPMAN MJ ROUIS M
Citation: M. Guerin et al., FAMILIAL LECITHIN - CHOLESTEROL ACYLTRANSFERASE DEFICIENCY - MOLECULAR ANALYSIS OF A COMPOUND HETEROZYGOTE - LCAT (ARG(147)-]TRP) AND LCAT (TYR(171)-]STOP), Atherosclerosis, 130, 1997, pp. 81-81
SMALL, DENSE LDL - ATHEROGENIC IMPACT AND NEW THERAPEUTIC APPROACHES
Authors: CHAPMAN MJ GUERIN M BRUCKERT E
Citation: Mj. Chapman et al., SMALL, DENSE LDL - ATHEROGENIC IMPACT AND NEW THERAPEUTIC APPROACHES, Atherosclerosis, 130, 1997, pp. 83-83
LIPOPROTEIN(A) IS A POTENT CHEMOATTRACTANT FOR HUMAN PERIPHERAL MONOCYTES
Authors: SYROVETS T THILLET J CHAPMAN MJ SIMMET T
Citation: T. Syrovets et al., LIPOPROTEIN(A) IS A POTENT CHEMOATTRACTANT FOR HUMAN PERIPHERAL MONOCYTES, Blood, 90(5), 1997, pp. 2027-2036
FENOFIBRATE REDUCES PLASMA CHOLESTERYL ESTER TRANSFER FROM HDL TO VLDL AND NORMALIZES THE ATHEROGENIC, DENSE LDL PROFILE IN COMBINED HYPERLIPIDEMIA
Authors: GUERIN M BRUCKERT E DOLPHIN PJ TURPIN G CHAPMAN MJ
Citation: M. Guerin et al., FENOFIBRATE REDUCES PLASMA CHOLESTERYL ESTER TRANSFER FROM HDL TO VLDL AND NORMALIZES THE ATHEROGENIC, DENSE LDL PROFILE IN COMBINED HYPERLIPIDEMIA, Arteriosclerosis, thrombosis, and vascular biology, 16(6), 1996, pp. 763-772
THE COMPLETE CDNA SEQUENCE ENCODING PLASMINOGEN FROM THE EUROPEAN HEDGEHOG (ERINACEUS-EUROPAEUS)
Authors: BELCZEWSKI AR LAPLAUD PM CHAPMAN MJ KOSCHINSKY ML
Citation: Ar. Belczewski et al., THE COMPLETE CDNA SEQUENCE ENCODING PLASMINOGEN FROM THE EUROPEAN HEDGEHOG (ERINACEUS-EUROPAEUS), Gene, 171(2), 1996, pp. 271-274
PLASMA-LIPOPROTEINS IN PRERUMINANT CALVES FED DIETS CONTAINING TALLOWOR SOYBEAN OIL WITH AND WITHOUT CHOLESTEROL
Authors: LEPLAIXCHARLAT L BAUCHART D DURAND D LAPLAUD PM CHAPMAN MJ
Citation: L. Leplaixcharlat et al., PLASMA-LIPOPROTEINS IN PRERUMINANT CALVES FED DIETS CONTAINING TALLOWOR SOYBEAN OIL WITH AND WITHOUT CHOLESTEROL, Journal of dairy science, 79(7), 1996, pp. 1267-1277
THE ATHEROGENIC ROLE OF TRIGLYCERIDES AND SMALL, DENSE LOW-DENSITY LIPOPROTEINS - IMPACT OF CIPROFIBRATE THERAPY
Authors: CHAPMAN MJ BRUCKERT E
Citation: Mj. Chapman et E. Bruckert, THE ATHEROGENIC ROLE OF TRIGLYCERIDES AND SMALL, DENSE LOW-DENSITY LIPOPROTEINS - IMPACT OF CIPROFIBRATE THERAPY, Atherosclerosis, 124, 1996, pp. 21-28
ABSENCE OF CHOLESTERYL ESTER TRANSFER PROTEIN-MEDIATED CHOLESTERYL ESTER MASS-TRANSFER FROM HIGH-DENSITY-LIPOPROTEIN TO LOW-DENSITY-LIPOPROTEIN PARTICLES IS A MAJOR FEATURE OF COMBINED HYPERLIPIDEMIA
Authors: GUERIN M BRUCKERT E DOLPHIN PJ CHAPMAN MJ
Citation: M. Guerin et al., ABSENCE OF CHOLESTERYL ESTER TRANSFER PROTEIN-MEDIATED CHOLESTERYL ESTER MASS-TRANSFER FROM HIGH-DENSITY-LIPOPROTEIN TO LOW-DENSITY-LIPOPROTEIN PARTICLES IS A MAJOR FEATURE OF COMBINED HYPERLIPIDEMIA, European journal of clinical investigation, 26(6), 1996, pp. 485-494
PHAGOCYTIC ACTIVATION INDUCES FORMATION OF PLATELET-ACTIVATING-FACTORIN HUMAN MONOCYTE-DERIVED MACROPHAGES AND IN MACROPHAGE-DERIVED FOAM CELLS RELEVANCE TO THE INFLAMMATORY REACTION IN ATHEROGENESIS
Authors: DENTAN C LESNIK P CHAPMAN MJ NINIO E
Citation: C. Dentan et al., PHAGOCYTIC ACTIVATION INDUCES FORMATION OF PLATELET-ACTIVATING-FACTORIN HUMAN MONOCYTE-DERIVED MACROPHAGES AND IN MACROPHAGE-DERIVED FOAM CELLS RELEVANCE TO THE INFLAMMATORY REACTION IN ATHEROGENESIS, European journal of biochemistry, 236(1), 1996, pp. 48-55
PEFABLOC, 4-[2-AMINOETHYL]BENZENESULFONYL FLUORIDE, IS A NEW, POTENT NONTOXIC AND IRREVERSIBLE INHIBITOR OF PAF-DEGRADING ACETYLHYDROLASE
Authors: DENTAN C TSELEPIS AD CHAPMAN MJ NINIO E
Citation: C. Dentan et al., PEFABLOC, 4-[2-AMINOETHYL]BENZENESULFONYL FLUORIDE, IS A NEW, POTENT NONTOXIC AND IRREVERSIBLE INHIBITOR OF PAF-DEGRADING ACETYLHYDROLASE, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1299(3), 1996, pp. 353-357
NONLINEAR COMPARTMENTAL MODEL INDISTINGUISHABILITY
Authors: CHAPMAN MJ GODFREY KR
Citation: Mj. Chapman et Kr. Godfrey, NONLINEAR COMPARTMENTAL MODEL INDISTINGUISHABILITY, Automatica, 32(3), 1996, pp. 419-422
PRAVASTATIN MODULATES CHOLESTERYL ESTER TRANSFER FROM HDL TO APO-B-CONTAINING LIPOPROTEINS AND LIPOPROTEIN SUBSPECIES PROFILE IN FAMILIAL HYPERCHOLESTEROLEMIA
Authors: GUERIN M DOLPHIN PJ TALUSSOT C GARDETTE J BERTHEZENE F CHAPMAN MJ
Citation: M. Guerin et al., PRAVASTATIN MODULATES CHOLESTERYL ESTER TRANSFER FROM HDL TO APO-B-CONTAINING LIPOPROTEINS AND LIPOPROTEIN SUBSPECIES PROFILE IN FAMILIAL HYPERCHOLESTEROLEMIA, Arteriosclerosis, thrombosis, and vascular biology, 15(9), 1995, pp. 1359-1368
TISSUE FACTOR PATHWAY INHIBITOR ACTIVITY ASSOCIATED WITH LDL IS INACTIVATED BY CELL-MEDIATED AND COPPER-MEDIATED OXIDATION
Authors: LESNIK P DENTAN C VONICA A MOREAU M CHAPMAN MJ
Citation: P. Lesnik et al., TISSUE FACTOR PATHWAY INHIBITOR ACTIVITY ASSOCIATED WITH LDL IS INACTIVATED BY CELL-MEDIATED AND COPPER-MEDIATED OXIDATION, Arteriosclerosis, thrombosis, and vascular biology, 15(8), 1995, pp. 1121-1130
PAF-DEGRADING ACETYLHYDROLASE IS PREFERENTIALLY ASSOCIATED WITH DENSELDL AND VHDL-1 IN HUMAN PLASMA - CATALYTIC CHARACTERISTICS AND RELATION TO THE MONOCYTE-DERIVED ENZYME
Authors: TSELEPIS AD DENTAN C KARABINA SAP CHAPMAN MJ NINIO E
Citation: Ad. Tselepis et al., PAF-DEGRADING ACETYLHYDROLASE IS PREFERENTIALLY ASSOCIATED WITH DENSELDL AND VHDL-1 IN HUMAN PLASMA - CATALYTIC CHARACTERISTICS AND RELATION TO THE MONOCYTE-DERIVED ENZYME, Arteriosclerosis, thrombosis, and vascular biology, 15(10), 1995, pp. 1764-1773
EFFECTS OF DIETARY-FAT AND L-METHIONINE ON THE HEPATIC-METABOLISM OF VERY-LOW-DENSITY LIPOPROTEINS IN THE PRERUMINANT CALF, BOS SPP
Authors: AUBOIRON S DURAND D ROBERT JC CHAPMAN MJ BAUCHART D
Citation: S. Auboiron et al., EFFECTS OF DIETARY-FAT AND L-METHIONINE ON THE HEPATIC-METABOLISM OF VERY-LOW-DENSITY LIPOPROTEINS IN THE PRERUMINANT CALF, BOS SPP, Reproduction, nutrition, development, 35(2), 1995, pp. 167-178
LIPOPROTEIN-(A) - A POTENT CHEMOATTRACTANT FOR HUMAN PERIPHERAL MONOCYTES EVIDENCE FOR INTERACTION WITH PLASMIN OGEN BINDING-SITES/
Authors: THILLET J CHAPMAN MJ SIMMET T
Citation: J. Thillet et al., LIPOPROTEIN-(A) - A POTENT CHEMOATTRACTANT FOR HUMAN PERIPHERAL MONOCYTES EVIDENCE FOR INTERACTION WITH PLASMIN OGEN BINDING-SITES/, Thrombosis and haemostasis, 73(6), 1995, pp. 1388-1388
CORE LIPID STRUCTURE IS A MAJOR DETERMINANT OF THE OXIDATIVE RESISTANCE OF LOW-DENSITY-LIPOPROTEIN
Authors: SCHUSTER B PRASSL R NIGON F CHAPMAN MJ LAGGNER P
Citation: B. Schuster et al., CORE LIPID STRUCTURE IS A MAJOR DETERMINANT OF THE OXIDATIVE RESISTANCE OF LOW-DENSITY-LIPOPROTEIN, Proceedings of the National Academy of Sciences of the United Statesof America, 92(7), 1995, pp. 2509-2513
NONENZYMATIC GLYCATION OF LIPOPROTEIN(A) IN-VITRO AND IN-VIVO
Authors: DOUCET C HUBY T RUIZ J CHAPMAN MJ THILLET J
Citation: C. Doucet et al., NONENZYMATIC GLYCATION OF LIPOPROTEIN(A) IN-VITRO AND IN-VIVO, Atherosclerosis, 118(1), 1995, pp. 135-143
TISSUE FACTOR PATHWAY INHIBITOR ACTIVITY ASSOCIATED WITH LDL IS INACTIVATED BY MINIMAL OXIDATION - RELEVANCE TO ATHEROTHROMBOSIS
Authors: LESNIK P DENTAN C VONICA A MOREAU M CHAPMAN MJ
Citation: P. Lesnik et al., TISSUE FACTOR PATHWAY INHIBITOR ACTIVITY ASSOCIATED WITH LDL IS INACTIVATED BY MINIMAL OXIDATION - RELEVANCE TO ATHEROTHROMBOSIS, Circulation, 92(8), 1995, pp. 3328-3328
PREFERENTIAL CHOLESTERYL ESTER ACCEPTERS AMONG THE LDL SUBSPECIES OF SUBJECTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
Authors: GUERIN M DOLPHIN PJ CHAPMAN MJ
Citation: M. Guerin et al., PREFERENTIAL CHOLESTERYL ESTER ACCEPTERS AMONG THE LDL SUBSPECIES OF SUBJECTS WITH FAMILIAL HYPERCHOLESTEROLEMIA, Arteriosclerosis and thrombosis, 14(5), 1994, pp. 679-685
PAF-ACETHER-DEGRADING ACETYLHYDROLASE IN PLASMA LDL IS INACTIVATED BYCOPPER-MEDIATED AND CELL-MEDIATED OXIDATION
Authors: DENTAN C LESNIK P CHAPMAN MJ NINIO E
Citation: C. Dentan et al., PAF-ACETHER-DEGRADING ACETYLHYDROLASE IN PLASMA LDL IS INACTIVATED BYCOPPER-MEDIATED AND CELL-MEDIATED OXIDATION, Arteriosclerosis and thrombosis, 14(3), 1994, pp. 353-360
NEW IN-VITRO METHOD FOR THE SIMULTANEOUS EVALUATION OF CHOLESTERYL ESTER EXCHANGE AND MASS-TRANSFER BETWEEN HDL AND APO-B-CONTAINING LIPOPROTEIN SUBSPECIES - IDENTIFICATION OF PREFERENTIAL CHOLESTERYL ESTER ACCEPTERS IN HUMAN PLASMA
Authors: GUERIN M DOLPHIN PJ CHAPMAN MJ
Citation: M. Guerin et al., NEW IN-VITRO METHOD FOR THE SIMULTANEOUS EVALUATION OF CHOLESTERYL ESTER EXCHANGE AND MASS-TRANSFER BETWEEN HDL AND APO-B-CONTAINING LIPOPROTEIN SUBSPECIES - IDENTIFICATION OF PREFERENTIAL CHOLESTERYL ESTER ACCEPTERS IN HUMAN PLASMA, Arteriosclerosis and thrombosis, 14(2), 1994, pp. 199-206
Risultati: 1-25 | 26-50 | 51-61